MONTREAL , Oct. 13, 2022 /CNW/ – AbbVie (NYSE: ABBV) and Fighting Blindness Canada have launched the particular Glaucoma in Perspective (GiP) app to help Canadians understand the impact of glaucoma plus manage disease progression. The launch associated with GiP coincides with World Sight Day, as the vision loss community comes together to raise awareness and understanding of eye diseases like glaucoma.
GiP was developed based on research and insights into patients’ perception associated with sight reduction with glaucoma. The app provides users with guidance on treatment regimen and includes a series of interactive demonstrations to encourage at-risk individuals to seek early intervention from a healthcare professional by allowing them to experience the impact of glaucoma on everyday situations. It also provides information on available treatment options to support glaucoma management.
“Fighting Blindness Canada is proud to support the particular launch associated with Glaucoma in Perspective within Canada . It’s an exciting opportunity to launch a new and innovative digital tool that can be easily accessible and help Canadians stay empowered in managing this disease, ” says Doug Earle , President and CEO of Fighting Loss of sight Canada. “We are hopeful that the Glaucoma within Perspective application will help both patients plus caregivers in understanding the complexities of glaucoma and provide valuable information to support the patient journey. inch
Glaucoma affects more than 728, 000 Canadians and takes the particular form associated with several related disease types, the most common being open angle glaucoma. 1 Glaucoma is characterized by a build-up of aqueous humour fluid and increased intraocular pressure (IOP) that damages the optic nerve. 2 There will be no cure for glaucoma, but earlier detection plus treatment can help prevent damage to the optic nerve, and as a result, save vision. 3
“Glaucoma is often known as the silent thief of sight and can frequently go undetected if there are no early symptoms. The goal of Glaucoma within Perspective is to provide a good user-friendly encounter for patients and caregivers to enhance their knowledge plus understanding of glaucoma to better assistance their needs, ” says Professor David Crabb , GiP app developer and Professor associated with Statistics plus Vision Research, City, University of London . “My hope is usually that Canadians will now have access to a digital tool that will assist them take more control of their own glaucoma and aid them in learning the condition. ”
In a national survey of 150 respondents with glaucoma, 69% of respondents didn’t know what type of glaucoma they have. 65% of respondents relied on their particular doctor’s office for new resources and information to aid their glaucoma knowledge while 39% search online. 4
“At AbbVie, we continue to explore new plus improved ways of enhancing glaucoma care for patients. While there is definitely no remedy for glaucoma, we remain dedicated in order to ensuring that individuals have access to available resources like Glaucoma in Perspective to support their own health and wellbeing, ” says Tracey Ramsay , Vice President and General Manager, AbbVie Canada. “We will continue to work collaboratively along with key partners, such as Fighting Blindness North america, to address the particular unmet requirements in glaucoma care plus help bring innovative solutions that provide meaningful effect for Canadians. inch
About Battling Blindness Europe
Combating Blindness Canada (FBC) is Canada’s leading charitable funder of eyesight research. FBC offers hope to Canadians by identifying the best, most promising research that is driving treatments and cures for blinding eye diseases. Over our 45-year history, FBC has invested over $40 million to back up vision study and education across North america: that’s over 200 analysis grants that have led in order to over 600 new discoveries understanding why vision loss occurs, how it can be slowed or stopped, and how sight can be restored. For more information, please visit www.FightingBlindness.ca .
AbbVie’s mission would be to discover plus deliver revolutionary medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health plus gastroenterology, within addition to products and services across its Allergan Aesthetics portfolio. To find out more about AbbVie, make sure you visit us at www.abbvie.ca . Follow @abbviecanada on Twitter and Instagram , or find us on LinkedIn.
SOURCE AbbVie Canada
For further information: Media: Muriel Haraoui, AbbVie Europe, 514-717-3764, [email protected]